BioSpace News Archive

Business

Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest

Acerus Pharmaceuticals Corporation today announced that it has entered into an exclusive agreement to commercialize Pharmanest AB (“Pharmanest”) Short Acting Lidocaine product (“SHACT”), a novel pain relief drug device combination in Canada.

May 29, 2018

·

7 min read

Bone Index: A Study Confirms - Bindex ® Point-of-care Technology is Extremely Cost-effective in Osteoporosis Management

A new study published in ClinicoEconomics and Outcomes Research reveals the immense cost-effectiveness and cost savings of Bindex®.

May 29, 2018

·

2 min read

Policy

Stallergenes Greer plc: Two New Real-World Evidence Studies Show Long-Term Benefits of Sublingual Allergy Immunotherapy

Stallergenes Greer announced positive results from two real-world evidence studies regarding the use of allergy immunotherapy (AIT) compared to the use of only symptomatic treatments to treat patients with respiratory allergies.

May 29, 2018

·

11 min read

Breakthrough hydrolysis technology transforms animal by-products and food waste into organic fertilizer and green energy.

An innovative Canadian technology targeting global markets has successfully completed commercial scale processing of livestock carcass by-products into fertilizers at the Lethbridge Biogas biorefining plant.

May 29, 2018

·

2 min read

Drug Development

Atox Bio Announces Enrollment of First Patient in Phase 2 Study of Acute Kidney Injury (AKI)

Atox Bio [http://www.atoxbio.com ], today announced that the first patient has been enrolled in the Phase 2 REAKT (Reltecimod E fficacy for Acute Kidney Injury T rial) study.

May 29, 2018

·

3 min read

Biotech Bay

Invokana: The Diabetic Drug That Costs a Limb

29 million people have type 2 diabetes in the U.S. making it big business for pharmaceutical companies.

May 29, 2018

·

2 min read

Why the Russian Pharmaceutical Market is Attractive for Foreign Generics, ARS PharmRussia Explains

The overseas generic pharmaceutical industry from the ICH region (US, Japan, EU) and ‘pharmerging’ countries have good opportunities to gain profits in Russia.

May 29, 2018

·

2 min read

Isolation and Recombinant Expression of Key Enzyme for Opioid Production

Intrexon Corporation announced the isolation and recombinant expression of a novel gene from the opium poppy (Papaver somniferum) encoding the enzyme, thebaine synthase.

May 29, 2018

·

5 min read

Drug Development

UCB Announces the Approval of CIMZIA® (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved extending the label for CIMZIA® (certolizumab pegol) to include a new indication in adults with moderate-to-severe plaque psoriasis.

May 29, 2018

·

25 min read

Pharm Country

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

Aevi Genomic Medicine, Inc. announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.

May 29, 2018

·

2 min read